Upsher Smith Laboratories, Inc.
Maple Grove, MN, United States
6
Total Recalls
0
Class I Recalls
0
Ongoing Recalls
Recalls by Upsher Smith Laboratories, Inc.
FDA Drug
Class II
Terminated
Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple Grove, MN 55369. NDC: 0832-0285-00
July 29, 2019
Upsher Smith Laboratories, Inc.
166 bottles units
FDA Drug
Class II
Terminated
Bumetanide Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0542-11
September 19, 2018
Upsher Smith Laboratories, Inc.
29,080 bottles units
FDA Drug
Class II
Terminated
Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11
September 19, 2018
Upsher Smith Laboratories, Inc.
44,764 bottles units
FDA Drug
Class III
Terminated
Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-027
April 14, 2014
Upsher Smith Laboratories, Inc.
1,185 bottles units
FDA Drug
Class III
Terminated
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0
December 10, 2012
Upsher Smith Laboratories, Inc.
11,316 bottles units
FDA Drug
Class II
Terminated
Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11
November 20, 2012
Upsher Smith Laboratories, Inc.
60 bottles units